732-58469-17925
3 vaccinations
7 coded responses
23 check-ins
7 free-text entries
4 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 986 / WA
- Registered
- 2021-01-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-26
Dose 1 — Pfizer-BioNTech
-
2021-01-27
Registered in v-safe
- 2021-01-27
-
2021-01-28
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea, Sinus congestion — Feeling: GoodFree text: Runny nose, sinus congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-30
-
2021-01-31
Survey response — days 1–6 daily, dose 1MedDRA: Paranasal sinus hypersecretion — Feeling: GoodFree text: Sinus dripMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-01
Survey response — days 1–6 daily, dose 1MedDRA: Hypotension — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Very low blood pressure eventually returning to normalMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-01
Report sent to call center — days 1–6 daily, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-02
- 2021-02-11
-
2021-02-16
Dose 2 — Pfizer-BioNTech
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-03-25
- 2021-03-30
- 2021-05-20
- 2021-06-15
-
2021-08-17
Survey response — 6 months, dose 2MedDRA: Pulmonary embolism, Supraventricular tachycardia, Thrombosis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Supraventricular tachycardia Pulmonary embolism Blood clots in legsMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-17
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-08-19
-
2021-09-06
Dose 3 — Pfizer-BioNTech
-
2021-09-29
Survey response — day 21, dose 3MedDRA: Pulmonary embolism, Pulmonary thrombosis, Supraventricular tachycardia, Thrombosis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Supraventricular tachycardia, leg and lung clots/ pulmonary embolismMedDRA releases: 2024-11 · check-in free text available
-
2021-09-29
Report sent to call center — day 21, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2021-09-30
- 2021-10-04
- 2021-10-05
- 2021-10-11
-
2021-10-18
Survey response — day 42, dose 3MedDRA: Cough, Headache, Sinus congestion — Feeling: GoodFree text: Sinus congestion, cough, headacheMedDRA releases: 2024-11 · check-in free text available
- 2021-12-06
- 2022-03-07
-
2022-09-06
Survey response — 12 months, dose 3MedDRA: COVID-19, Lung disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: COVID 19 despite 2 vaccinations and 2 boosters. Symptoms lasted 4 days with pulmonary weakness for another 2 week. Date of first symptoms July 4. Had used masks consistently.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-06
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-09-07
- 2022-09-07
- 2022-09-07
- 2022-09-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-26 | Pfizer-BioNTech | |
| 2 | 2021-02-16 | Pfizer-BioNTech | |
| 3 | 2021-09-06 | Pfizer-BioNTech | No |
Call center
4 call center cases
4 unsuccessful
1 wait over 3 months for a first call
Free text
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): Runny nose, sinus congestion
Systemic reaction (other): Sinus drip
Systemic reaction (other): Very low blood pressure eventually returning to normal
Release 9 — 6 months, dose 2
Symptoms: Supraventricular tachycardia Pulmonary embolism Blood clots in legs
Release 9 — day 21, dose 3
Symptoms: Supraventricular tachycardia, leg and lung clots/ pulmonary embolism
Release 10 — day 42, dose 3
Symptoms: Sinus congestion, cough, headache
Release 12 — 12 months, dose 3
Symptoms: COVID 19 despite 2 vaccinations and 2 boosters. Symptoms lasted 4 days with pulmonary weakness for another 2 week. Date of first symptoms July 4. Had used masks consistently.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Lung disorder | · | · | ✓ |
| SD | Pulmonary embolism | ✓ | · | ✓ |
| SD | Pulmonary thrombosis | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Supraventricular tachycardia | ✓ | · | ✓ |
| SD | Thrombosis | ✓ | · | ✓ |
| SRO | Hypotension | ✓ | ✓ | ✓ |
| SRO | Paranasal sinus hypersecretion | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Sinus congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release